How should I use Lotemax(loteprednol etabonat)?

The recommended dosage is a fixed dose administered intravenously every 4 weeks.

Recommended Dosage and Infusion

The recommended dosage for eligible patients is 480 mg of nivolumab and 160 mg of relatlimab administered as an intravenous infusion over 30 minutes every 4 weeks. Treatment should continue until disease progression or unacceptable toxicity occurs. The vial contents must be inspected for particulates or discoloration before use, and the solution can be administered diluted or undiluted, following specific preparation and storage guidelines.